These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


323 related items for PubMed ID: 37011669

  • 1. Transgender health and the impact of aging and menopause.
    Cheung AS, Nolan BJ, Zwickl S.
    Climacteric; 2023 Jun; 26(3):256-262. PubMed ID: 37011669
    [Abstract] [Full Text] [Related]

  • 2. Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia.
    Nolan BJ, Cheung AS.
    Intern Med J; 2024 Sep; 54(9):1450-1457. PubMed ID: 39056542
    [Abstract] [Full Text] [Related]

  • 3. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
    Jasuja GK, Wolfe HL, Reisman JI, Vimalananda VG, Rao SR, Blosnich JR, Livingston NA, Shipherd JC.
    Front Endocrinol (Lausanne); 2024 Sep; 15():1086158. PubMed ID: 38800485
    [Abstract] [Full Text] [Related]

  • 4. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
    Sudhakar D, Huang Z, Zietkowski M, Powell N, Fisher AR.
    Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
    [Abstract] [Full Text] [Related]

  • 5. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
    Salakphet T, Mattawanon N, Manojai N, Muangmool T, Tangpricha V.
    J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
    Shepherd R, Bretherton I, Pang K, Mansell T, Czajko A, Kim B, Vlahos A, Zajac JD, Saffery R, Cheung A, Novakovic B.
    Clin Epigenetics; 2022 Feb 17; 14(1):24. PubMed ID: 35177097
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
    Foster Skewis L, Bretherton I, Leemaqz SY, Zajac JD, Cheung AS.
    Front Endocrinol (Lausanne); 2021 Feb 17; 12():717766. PubMed ID: 34394009
    [Abstract] [Full Text] [Related]

  • 13. Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition.
    Nguyen HB, Chavez AM, Lipner E, Hantsoo L, Kornfield SL, Davies RD, Epperson CN.
    Curr Psychiatry Rep; 2018 Oct 11; 20(12):110. PubMed ID: 30306351
    [Abstract] [Full Text] [Related]

  • 14. Sex hormones, insomnia, and sleep quality: Subjective sleep in the first year of hormone use in transgender persons.
    Morssinkhof MWL, Wiepjes CM, Bosman BW, Kinds J, Fisher AD, Greenman Y, Kreukels BPC, T'Sjoen G, van der Werf YD, Heijer MD, Broekman BFP.
    Sleep Med; 2023 Jul 11; 107():316-326. PubMed ID: 37271109
    [Abstract] [Full Text] [Related]

  • 15. Long-term effect of gender-affirming hormone treatment on depression and anxiety symptoms in transgender people: A prospective cohort study.
    Aldridge Z, Patel S, Guo B, Nixon E, Pierre Bouman W, Witcomb GL, Arcelus J.
    Andrology; 2021 Nov 11; 9(6):1808-1816. PubMed ID: 32777129
    [Abstract] [Full Text] [Related]

  • 16. Routine Screening for Transgender and Gender Diverse Adults Taking Gender-Affirming Hormone Therapy: a Narrative Review.
    Iwamoto SJ, Grimstad F, Irwig MS, Rothman MS.
    J Gen Intern Med; 2021 May 11; 36(5):1380-1389. PubMed ID: 33547576
    [Abstract] [Full Text] [Related]

  • 17. Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people.
    Santi D, Spaggiari G, Marinelli L, Cacciani M, Scipio S, Bichiri A, Profeta A, Granata ARM, Simoni M, Lanfranco F, Manieri C, Ghigo E, Motta G.
    J Endocrinol Invest; 2024 May 11; 47(5):1091-1100. PubMed ID: 37889433
    [Abstract] [Full Text] [Related]

  • 18. Effect of gender-affirming hormone therapy on hair growth: a systematic review of the literature.
    Tang GT, Zwickl S, Sinclair R, Zajac JD, Cheung AS.
    Clin Exp Dermatol; 2023 Sep 19; 48(10):1117-1127. PubMed ID: 37311161
    [Abstract] [Full Text] [Related]

  • 19. MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
    Glintborg D, T'Sjoen G, Ravn P, Andersen MS.
    Eur J Endocrinol; 2021 Jun 28; 185(2):R49-R63. PubMed ID: 34081614
    [Abstract] [Full Text] [Related]

  • 20. Considerations for the care of transgender patients in orthopaedics and sports medicine: a narrative review.
    Hayes-Lattin M, Krivicich LM, Bragg JT, Rogerson A, Salzler MJ.
    Br J Sports Med; 2024 Sep 09; 58(18):1075-1082. PubMed ID: 38997148
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.